1997
DOI: 10.1038/sj.bmt.1700624
|View full text |Cite
|
Sign up to set email alerts
|

Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation

Abstract: Summary:blood stem cell transplantation than after allo-BMT, resulting in less morbidity and mortality. 3,4 There are relatively little data about the reconstitution of lymphocyte subThe expression of CD45RA + and CD45RO + isoforms on T cells and the recovery of B lymphocytes and NK cells sets after PBSCT. 5 B cell reconstitution is severely compromised for months to years after allo-BMT, 6 especially in after autologous peripheral blood stem cell transplantation (PBSCT) were studied during the early period … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
58
0
2

Year Published

2000
2000
2013
2013

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 83 publications
(67 citation statements)
references
References 2 publications
7
58
0
2
Order By: Relevance
“…Our immunophenotypic studies confirm and extend earlier observations on T-cell reconstitution after autologous SCT: (i) a very protracted recovery of CD4 þ Tcells, 9,15,29,30 in particular that of the 'naive' CD4 þ , 45R0 À (ECD45RA þ ) subset; 16,[31][32][33] within the 'primed' CD4 þ , 45R0 þ T-cells, the 'central memory' cells expressing the CD62L and CD27 markers were the slowest to recover; 15,16 (ii) a relatively slow recovery of TCR-gd þ T-cells; (iii) a rapid normalization of CD8 þ T-cell counts; 8,15,[29][30][31]33 (iv) initially, a strong upregulation of HLA-DR expression by TCRab þ T-cells, gradually declining to normal at 12 months; 12,30 and (v) upregulation of the apoptosis marker CD95, in particular by the CD4 þ T-cells. 16,34 With respect to cytokine responses, our observation that the capability of CD4 þ and CD8 þ T-cells to produce IFN-g, IL-2 and TNF-a had reached their normal ranges from 2 months post SCT onwards is consistent with that of others.…”
Section: Discussionsupporting
confidence: 79%
“…Our immunophenotypic studies confirm and extend earlier observations on T-cell reconstitution after autologous SCT: (i) a very protracted recovery of CD4 þ Tcells, 9,15,29,30 in particular that of the 'naive' CD4 þ , 45R0 À (ECD45RA þ ) subset; 16,[31][32][33] within the 'primed' CD4 þ , 45R0 þ T-cells, the 'central memory' cells expressing the CD62L and CD27 markers were the slowest to recover; 15,16 (ii) a relatively slow recovery of TCR-gd þ T-cells; (iii) a rapid normalization of CD8 þ T-cell counts; 8,15,[29][30][31]33 (iv) initially, a strong upregulation of HLA-DR expression by TCRab þ T-cells, gradually declining to normal at 12 months; 12,30 and (v) upregulation of the apoptosis marker CD95, in particular by the CD4 þ T-cells. 16,34 With respect to cytokine responses, our observation that the capability of CD4 þ and CD8 þ T-cells to produce IFN-g, IL-2 and TNF-a had reached their normal ranges from 2 months post SCT onwards is consistent with that of others.…”
Section: Discussionsupporting
confidence: 79%
“…However, it does not necessarily reflect all functional changes of the system. 35,36 After transplantation with unmanipulated PBPC graft, only CD4 + CD45RA + (naive helper cells) undergo thymic dependent regeneration. They recover much more slowly than their memory counterparts (CD4 + CDRO + cells), which recover via the extrathymic pathway.…”
Section: Discussionmentioning
confidence: 99%
“…Unlike patients who underwent ASCT without rituximab, in whom B-cell recovery occurred between 3 and 6 months, [2][3][4] we observed severe delays in the immunoglobulin recoveries in these patients (Figure 1a). At 9 months after transplant, all patients were IgM and IgG deficient, with only one patient who achieved a normal IgA level.…”
mentioning
confidence: 93%